Severe immune-related adverse events of immune checkpoint inhibitors for advanced non-small cell lung cancer: a network meta-analysis of randomized clinical trials
Jingjing Gu, Lei Shi, Xiaowen Jiang, Jianhua Wen, Xiaoming Zheng, Cai Hu, Weidong Zhang
Topics & Concepts
NivolumabAtezolizumabDurvalumabPembrolizumabMedicineIpilimumabOncologyInternal medicineLung cancerAdverse effectPneumonitisCancerImmunotherapyLungCancer Immunotherapy and BiomarkersInflammatory Biomarkers in Disease PrognosisLung Cancer Research Studies